# Takeda Pharmaceuticals USA, Inc. – FDA Inspection, Sep 9, 2016

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa-inc/79ce5fb5-95a6-43f1-b5a1-8073b2a5b82a
Source feed: FDA_Inspections

> FDA inspection 988237 of Takeda Pharmaceuticals USA, Inc., September 09, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 988237
- Company Name: Takeda Pharmaceuticals USA, Inc.
- Inspection Date: 2016-09-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1107731 - 2019-10-25
- FDA Inspection 818340 - 2013-01-28
- [FDA Inspection 811093 - 2013-01-18](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa-inc/9a2e2493-95a8-4426-a28d-f249cb9a6c6d)
- FDA Inspection 756349 - 2011-12-08
- FDA Inspection 662088 - 2010-04-27

Company: https://www.keypedia.com/companies/takeda-pharmaceuticals-usa-inc/678d8802-0216-41d5-bdd6-38999c144876

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c